Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ulta Beauty Inc (ULTA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Ulta Beauty IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Ulta Beauty Inc vs Zimmer Biomet Holdings Inc — how do they compare? Ulta Beauty Inc trades at $535.64 (market cap $23.27B), while Zimmer Biomet Holdings Inc trades at $96.01 (market cap $18.55B). The key difference: Ulta Beauty Inc is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals.

ULTAZBH
Market Cap
$23.27B$18.55B
Sector
Consumer CyclicalHealth
52-Week High
$706.82$107.71
52-Week Low
$450.75$79.58
Enterprise Value
$25.35B$25.61B
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ulta Beauty Inc

Ulta Beauty (ULTA) trades at $537.69, down 2.0% today, with a bullish technical outlook from moving averages and a consensus analyst price target of $618.29. Recent earnings show mixed quarterly beats, with Q1 2026 EPS of $7.74 exceeding expectations, while revenue growth remains steady at $11.3B for 2025. The company maintains strong profitability with a net margin of 9.36% and ROE of 47.45%, supported by an omnichannel strategy highlighted in recent news.

The stock presents a buy opportunity with Wall Street optimism (56.53% buy ratings) and solid fundamentals, but risks include margin compression from rising costs and competitive pressures. Near-term catalysts include the Q2 2026 earnings report, with expected EPS of $6.17, and the transition from the Target partnership, viewed as a growth opportunity by analysts.

Zimmer Biomet Holdings Inc

ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.

The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.

Returns comparison

Trailing returns across standard periods

About Ulta Beauty Inc

With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.

Read more on ULTA

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH